Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 2 × Advanced Cancer × linrodostat × Clear all

Phase

Phase 2 2 Phase 1/2 2 Phase 1 1

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Advanced Cancer 2 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Non-Muscle Invasive Bladder Neoplasms 1 Melanoma 1 Lymphoid Interstitial Pneumonia 1 Laryngeal Diseases 1 Carcinoma, Squamous Cell 1 Advanced Gastric Cancer 1

Interventions

relatlimab 2 linrodostat 2 Nivolumab 2 Ipilimumab 2 Vorinostat 1 Trastuzumab 1 IFL protocol 1 Gemcitabine 1 Dasatinib 1 Cetuximab 1 BMS-813160 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02996110 2022-12-19

FRACTION-RCC

Bristol-Myers Squibb

Phase 2 Completed

182 enrolled 23 charts

Advanced Cancer

NCT02750514 2021-03-22

FRACTION-Lung

Bristol-Myers Squibb

Phase 2 Terminated

295 enrolled 21 charts

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡